Localization of authentic thromboxane A2lprostaglandin H2 receptor in the rat kidney. Using a polyclonal antibody against authentic thromboxane A2/prostaglandin H2 (TxA2/PGH2) receptor protein, we assessed the distribution of this receptor in the normal rat kidney by routine methods of immunofluorescence microscopy. The receptor localized both in gbmeruli and in tubules. In the former, the distribution of the receptor was most prominent along the lumen of glomerular capillary ioops. Parietal epithelial cells of the Bowman's capsule, podocytes and mesangial cells also demonstrated immunostainable receptor. In the tubules, the receptor localized most prominently at the base of the brush border of proximal tubules and at the luminal surface of thick ascending limbs and distal convoluted tubules. These observations point to sites that are likely to be targeted by thromboxane A2 in forms of renal injury characterized by enhanced synthesis of this eicosanoid.
Multiple studies addressing the synthesis and cell origin of thromboxane A2 (TxA2) by renal tissue have employed the rat kidney. These studies have shown that TxA2 is mainly produced in the glomerulus and that its production is either minimal or undetectable in renal tubular epithelium [1, 2] . The cellular origin of glomerular TxA2 synthesis was further explored by assessing its production in cultured glomerular cells, and it was shown that it is mainly produced by glomerular mesangial cells. Its synthesis under basal or stimulated conditions in glomerular epithelial or endothelial cells is minimal or undetectable.
TxA2 is not the major eicosanoid synthesized by normal gbmeruli or by cultured glomerular cells. Its abundance is substantially lower than that of other eicosanoids such as prostaglandin (PG) F2,, and PGE2. However, following glomerular injury, production of TxA2 by isolated glomeruli is markedly enhanced. This was shown in a number of experimental models of glomerular injury including antibody-mediated injury, diabetic glomerulopathy and renal allograft rejection [reviewed in 3] . In these conditions, particularly in glomerular immune injury, TxA2 has been shown to originate from inflammatory cells, mainly activated leukocytes and platelets, that infiltrate the glomerular structures [4] . Once released by these cells, TxA2 can act in a paracrine manner on intrinsic glomerular cells (endothelial, mesangial, and epithelial) to induce a number of biologic effects. These have best been
Received for publication September 27, 1995 and in revised form November 21, 1995 Accepted for publication November 22, 1995 © 1996 by the International Society of Nephrology characterized in cultured mesangial cells which possess functional, high affinity receptor sites for TxA2 [5] . Binding of TxA2 to mesangial cell receptors induces a number of signaling events and biologic responses including activation of a phosphatidylinositolspecific phospholipase C, activation of protein kinase C and enhanced DNA synthesis [6] , contraction [7] , and enhanced production of extracellular matrix [8] . Despite this impressive array of biologic events induced by TxA2 on glomerular cells, the localization and distribution of TxA2 receptors in the glomerulus and the kidney has only recently been explored. Knowledge of the location and abundance of TxA2 receptors within the kidney will enhance our understanding of the role of this eicosanoid in renal physiology and will identify sites of the nephron that are likely to be targeted by TxA2 in forms of renal injury characterized by augmented TxA2 production. The present studies employed a polyclonal antibody raised against authentic thromboxane A2! prostaglandin H2 (TxA2/PGH2) receptor protein to localize this receptor in the normal rat kidney.
Methods
Antibody against native TxA2/PGH2 receptor protein Two polyclonal antibodies developed by Borg et al [9, 10] were employed: (a) an antibody raised against the TxA2/PGH2 receptor protein [9] . The 55 kDa receptor protein was purified from platelets using ligand affinity chromatography [10] . Briefly, solubilized platelet membranes were subjected to affinity chromatography and eluted with the TxA2/PGH2 receptor antagonist BM13.177 [111. The BM13.177 eluate fractions containing receptor protein were lyophilized and subjected to SDS-PAGE using 7 .5% slab gels. The 55 kDa area of the gel was then sliced and the receptor protein was electrophoretically eluted and used for immunizations to raise the anti-receptor protein antibody. In platelet TxA2/PGH2 receptor protein (55 kDa), and recognized a single band (55 kDa) in solubilized platelet membranes [12] .
Preparation of kidney for immunohistology
Male Sprague-Dawley rats (200 to 350 g, Harland Industries, Madison, WI, USA) were anesthesized with mactin and maintained at 37°C on a contast temperature table. The kidneys were perfused in situ via a canula inserted in the inferior abdominal aorta while the aorta above the renal arteries was tied off. The kidneys were perfused via a pump that delivered perfusate under 30 mm Hg. Perfusions were performed sequentially with 50 ml heparinized saline, 100 ml 1% paraformaldehyde and 2.5% glutaraldehyde in phosphate buffered saline, pH 7.4, followed by Figure 2 . Localization in glomerular parietal epithelial cells, in a podocyte (arrow) and in the brush border of the surrounding tubules is apparent.
In Figure 3 , binding and distribution of the anti-TxA2IPGH2 receptor antibody in glomerular structures is shown. Localization of the receptor was most prominent in the wall of glomerular capillaries in a linear continuous pattern surrounding the capillary lumen. Localization of the receptor was also apparent in podocytes and mesangial areas.
In Figure 4 , binding of the anti-TxA2/PGH2 receptor antibody (Fig. 4A) and of the anti-C-terminal region decapeptide (Fig. 4B) in glomerular capillaries is shown. A similar pattern of distribution around the capillary lumen was obtained. antigen was used, there were no positive binding signals (Fig. 5B ) as compared to non-absorbed receptor antibody (Fig. 5A) .
In Figure 6 localization of the TxA2IPGH2 receptor is shown in renal cortical tubules. The receptor localized at the base of the brush border of proximal tubules (Fig. 6A) , and also at or near the luminal surface of thick ascending or distal convoluted tubules (Fig. 6B) . In the latter, vesicular structures demonstrating positive immunostaining for the receptor were apparent at or just below the luminal surface and within the tubular cells (Fig. 6B) .
Discussion Although the role of TxA2 in regulating the glomerular microcirculation and in the pathophysiology of various forms of gbmerular injury has been extensively studied, studies characterizing the distribution of thromboxane A2 receptor in the kidney are only recently emerging. Abe and coinvestigators have recently described the intrarenal expression of the thromboxane receptor in the rat kidney [13] . Using a rat kidney thromboxane receptor cDNA, they examined expression of thromboxane receptor mRNA in the kidney by methods of in situ hybridization or reverse transcription-polymerase chain reaction (RT-PCR) applied to microdissected nephron segments. They demonstrated that the thromboxane receptor was expressed specifically in the renal glomerulus, in arterial smooth muscle cells and in the transitional cell epithelium of the renal pelvis. Mannon, Coffman and Mannon employed a receptor autoradiography approach using the radio labeled (1-BOP), and detected specific binding of this agonist throughout the kidney, the highest density of specific binding being localized to the medulla, glomeruli and to small and medium sized arteries. There was a paucity of receptors in the juxtamedullary region and in the papilla [14] .
To further explore the localization of the thromboxane receptor in the kidney, we performed the present immunolocalization studies using a polycbonal antibody raised against authentic TxA2/ PGH2 receptor protein purified by ligand affinity chromatography.
This antibody reacts with purified platelet TxA2/PGH2 receptor protein and identifies a single protein band at 55 kDa in solubilized platelet membranes [9, 10] . This 55 kDa protein specifically binds the thromboxane A2 receptor antagonist [3H] SQ29548, and immunohistochemical studies using an antibody against this protein (employed in the present studies) have localized the TxA2/ PGH2 receptor in rat brain, rabbit aorta and human platelets [9] . Our results indicate that the native TxA2/PGH2 receptor protein is distributed in glomeruli and in tubules of the rat kidney cortex. In the glomerulus, its localization was apparent in capillary loops as a linear continuous pattern surrounding the lumen of the capillaries (best shown in Fig. 4A ), in parietal epithelial cells of the Bowman's capsule and podocytes (Fig. 2) , and in the mesangium (Fig. 3) . Immunolocalization was most prominent and distinct in capillary loops rather than the mesangium (Figs. 3 and   4 ). The binding pattern of the antibody raised against the Cterminal receptor region decapeptide to glomerular capillaries was similar to that obtained with the anti-TxA2/PGH2 receptor protein (Figs. 4 A, B) . The anti-decapeptide antibody employed does not block platelet aggregation induced by ADP or by the TxA2 mimetic U-46619, nor does it block binding of the TxA2 receptor antagonist SQ-29,548 to the solubilized receptor [12] . Therefore, this antibody identifies epitopes that are separate from the TxA2/PGH2 binding domain of the receptor.
The apparent differences in sites of localization observed in the present study and that by Abe et a! [13] are most likely due to the different methodologic approaches employed. Thus, the inability to detect thromboxane receptor mRNA in isolated tubular segments using in situ hybridization and RT-PCR methods in the studies by Abe et al may be due to the existence of TxA2/PGH2 receptor subtypes that cannot be detected by the cRNA fragment or oligonucleotide primers employed in these studies. The existence of such a subtype is supported by an earlier report which With respect to tubular localization of native TxA2 receptor, our observations identify prominent expression of the receptor at the base of the brush border of proximal tubules where it is distributed in a linear pattern (Fig. 6A) , and at the luminal surface and within vesicular formations of thick ascending or distal convoluted tubules (Fig. 6B) . These tubules are likely to be thick ascending or distal convoluted as they lack intercalating cells, which typically bulge into the lumen and arc only present in connecting tubular segments and collecting ducts. The functional significance of the differences in the pattern of distribution of the native TxA2IPGH2 receptor in renal tubules awaits investigation.
The tubular epithelium is likely to get exposed to substantial amounts of TxA2 generated by inflammatory cells infiltrating the glomerular capillary in the course of various forms of glomerular injury. Filtration of thromboxane following injury and binding to renal tubular epithelium is quite likely to occur in view of the presence of TxA2 receptors in this epithelium. The pathophysiologic significance of this event is only speculative. Studies assessing signalling events and physiologic responses generated as a result of TxA2 binding to renal tubular epithelial cells are lacking. Possible effects may include activation by TxA, of phospholipase C and protein kinase C, as we and others have demonstrated in glomerular mesangial cells [5, 6] , thereby modulating transport mechanisms of this epithelium.
In summary, using a polyclonal antibody against authentic TxA2/PGH2 receptor protein we have localized this receptor in the normal rat glomerulus and tubular epithelium. Prominent sites of localization were the glomerular capillaries and glomerular epithelial cells, the base of brush border of proximal tubular cells, and the luminal surface of thick ascending or distal convoluted tubules.
